Skip to contentApplication 090130
- Type
- ANDA
- Sponsor
- ACTAVIS TOTOWA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PACLITAXEL | PACLITAXEL | INJECTABLE;INJECTION | 6MG/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 45963-613 | Paclitaxel | Paclitaxel | Actavis Pharma, Inc. | ANDA | Current |
| 45963-613 | Paclitaxel | Paclitaxel | Actavis Pharma, Inc. | ANDA | Current |
| 45963-613 | Paclitaxel | Paclitaxel | Actavis Pharma, Inc. | ANDA | Current |
| 45963-613 | Paclitaxel | Paclitaxel | Actavis Pharma, Inc. | ANDA | Current |
| 45963-613 | Paclitaxel | Paclitaxel | Actavis Pharma, Inc. | ANDA | Current |
| 45963-613 | Paclitaxel | Paclitaxel | Actavis Pharma, Inc. | ANDA | Current |
| 45963-613 | Paclitaxel | Paclitaxel | Actavis Pharma, Inc. | ANDA | Current |
| 63323-763 | Paclitaxel | Paclitaxel | Fresenius Kabi USA, LLC | ANDA | Current |